Stevanato Group S.p.A ($STVN) Insider Trading & Smart Money Activity

Stevanato Group S.p.A. · Medical Instruments & Supplies · Latest filing Oct 16, 2026

Stevanato Group S.p.A. ($STVN) has 16 insider trades, 1 13F position change and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 5 insiders sold ($395.51K), net -$395.51K.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
5
Net insider $ (12 mo)
-$395.51K
Congress trades (12 mo)
0
13F moves on file
1
Analyst ratings on file
1

STVN insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 4 · $102.06K 0 / 0 0 / 0
Q3 2026 0 1 · $293.45K 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 1 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All STVN insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F PineStone Asset Management Added +3.20K sh $867.21K —
Insider Stocchi MauroChief Business Strategy Officer Sell (Open-market sale) 13.65K sh $293.45K -6.4% —
Analyst TD Cowen Reiterates to buy PT $25 +2.2%+21.7% Read
Insider Morel Donald JR Sell (Open-market sale) 1.49K sh $25.52K +1.9%+13.7% Read
Insider Karen Flynn Sell (Open-market sale) 1.49K sh $25.52K +1.9%+13.7% Read
Insider William Federici Sell (Open-market sale) 1.49K sh $25.52K +1.9%+13.7% Read
Insider Madhavan Balachandran Sell (Open-market sale) 1.49K sh $25.52K +1.9%+13.7% Read
Insider Luciano Santel Buy (Grant or award) 4.97K sh -0.8%+15.8% Read
Insider Morel Donald JR Buy (Grant or award) 4.97K sh -0.8%+15.8% Read
Insider Elisabetta Magistretti Buy (Grant or award) 4.97K sh -0.8%+15.8% Read
Insider Sue-Jean Lin Buy (Grant or award) 4.97K sh -0.8%+15.8% Read
Insider Karen Flynn Buy (Grant or award) 4.97K sh -0.8%+15.8% Read
Insider William Federici Buy (Grant or award) 4.97K sh -0.8%+15.8% Read
Insider Dal Lago MarcoChief Financial Officer Sell (Option exercise) 8K sh -0.8%+15.8% Read
Insider Dal Lago MarcoChief Financial Officer Buy (Option exercise) 8K sh -0.8%+15.8% Read
Insider Madhavan Balachandran Buy (Grant or award) 4.97K sh -0.8%+15.8% Read
Insider Mauro StocchiChief Business Strategy Officer Sell (Option exercise) 6.59K sh -8.4%+9.5% Read
Insider Mauro StocchiChief Business Strategy Officer Buy (Option exercise) 6.59K sh -8.4%+9.5% Read

1W / 1M / 6M = how STVN moved from the trade or filing date.

Insider trading in STVN: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Stocchi Mauro Chief Business Strategy Officer 1 -$293.45K Sep 28, 2026
Morel Donald JR 2 -$25.52K Jun 15, 2026
Karen Flynn 2 -$25.52K Jun 15, 2026
William Federici 2 -$25.52K Jun 15, 2026
Madhavan Balachandran 2 -$25.52K Jun 15, 2026
Dal Lago Marco Chief Financial Officer 2 — Jun 12, 2026
Luciano Santel 1 — Jun 12, 2026
Elisabetta Magistretti 1 — Jun 12, 2026
Sue-Jean Lin 1 — Jun 12, 2026
Mauro Stocchi Chief Business Strategy Officer 2 — Jun 9, 2026

Institutions moving STVN (13F)

Analyst ratings on STVN

DateFirmActionRatingPrice target1W1M6MStory
TD Cowen Reiterates buy $25 +2.2%+21.7% Read

Frequently asked questions

Are STVN insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 5 insiders made 5 open-market sales worth $395.51K, a net -$395.51K.

What is the latest insider trade in STVN?

Stocchi Mauro, Chief Business Strategy Officer filed a sell (open-market sale) of 13.65K sh worth $293.45K on Sep 28, 2026.

Which institutions changed their STVN positions?

Recent 13F filers moving the stock include PineStone Asset Management.

Other medical instruments & supplies stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text